Embed Size (px)
Citation preview
USA – CANADA – UK – CHINA – INDIA
Global Inflammatory Bowel Disease Market 2015-2019
The report discusses the following in-depth:
• Market Size and Forecast
• Market Segmentation
• Buying Criteria
• Vendor Landscape
• Business Segmentation
• Geographical Segmentation
For more information on the
Global Inflammatory Bowel Disease Market 2015-2019,
please mail us [email protected]
USA – CANADA – UK – CHINA – INDIA
Key Trends
Technavio’s Senior Analyst says, “The high prevalence of inflammatory bowel disease among the population resulting in a rise in the number of treatment-seeking patients has led to increased consumption of medications, thereby having a positive impact on the market share of the vendors. The presence of high unmet medical needs is another major factor in the market.”
• Inflammatory bowel diseases are a group of autoimmune conditions such as Crohn's disease and ulcerative colitis that cause chronic inflammation in any part of or the entire GI tract. Ulcerative colitis generally causes inflammation and leads to the formation of ulcers in the innermost lining of the colon and the rectum of the patient.
• The global inflammatory bowel disease market is expected to grow moderately and post a CAGR of 3.95% during the forecast period.
• Understanding the key drivers influencing the market
• Understanding the challenges faced by the market
• Activities of various stakeholders involved
• Key focus areas for the vendors
• Major trends that will shape the future of this market
• Vendor landscape and trajectory of the market
• Conclusion
Scope of The Report
A detailed analysis of each market driver, challenge
and trend isavailable in our report:
Global Inflammatory Bowel Disease Market 2015-2019
USA – CANADA – UK – CHINA – INDIA
USA – CANADA – UK – CHINA – INDIA
Vendors
To understand the vendor landscape and for a full list
of vendors view our report:
Global Inflammatory Bowel Disease Market
2015-2019
AbbVie Inc.
Biogen Idec Inc.
Janssen Pharmaceuticals Inc.
AbbVie is a biopharmaceutical company that develops and markets pharmaceutical products worldwide. The company has a patient-centric approach, is committed to its patients, and strives to identify opportunities to craft a better result at every phase.
It develops, manufactures, and markets novel human therapeutics.In April 2013, Biogen Idec completed its acquisition of Elan PharmaInternational along with all strategic, commercial, and decision-making rights. In 2013, the company relocated to its corporateheadquarters in Cambridge, Massachusetts, US, to furtherstrengthen its R&D.
Janssen Pharmaceuticals is a pharmaceutical company ofJohnson & Johnson which is an American medical device,pharmaceuticals and consumer packaged goods manufacturer.Janssen provides medicines for health concerns in therapeuticareas like attention deficit hyperactivity disorder ADHD, generalmedicine, mental health, neurologics, pain management, andwomen’s health.
USA – CANADA – UK – CHINA – INDIA
Market Landscape
• The global inflammatory bowel disease market is expected to grow moderatelyduring the forecast period because of the increased prevalence of ulcerativecolitis and Crohn's disease in the population, especially in developed countries.
• The US is a major revenue contributor to the market, followed by Europe.
• The expected launch of new drugs for the treatment and management ofinflammatory bowel disease will propel the growth of the market.
• However, the high cost of drugs used for the treatment of the disease inhibit themarket growth.
• In addition, major branded biologics such as Humira and Remicade are set to losetheir market exclusivity during the forecast period, which will cause a decline inthe market growth.
USA – CANADA – UK – CHINA – INDIA
Key Buying Criteria
Guest Bloggers
• Authenticity • Delivery • Price• Service
Support
Parameter Details
Availability Drugs for inflammatory bowel disease should be readily
available in the market.
Efficacy
Drugs for inflammatory bowel disease should be
efficient and show positive results.
Safety
Drugs for inflammatory bowel disease should be safe
and have minimum adverse effects.
Affordability Drugs for inflammatory bowel disease should be priced
reasonably.
• Growth Forecasts?
• Market Analysis?
• Revenue Forecasts?
• Regional and Country level Analysis?
• Competitive Structure?
• Emerging Trends?
• Vendor Landscape?
• Other?
What Would You Like to Learn From Technavio?
Global Inflammatory Bowel Disease Market
2015-2019
Let us identify your needs.We would love to hear more!
USA – CANADA – UK – CHINA – INDIA
Our Report Covers:Market Scenarios, Vendor landscape & Industry Road Maps.
You have the Option to CustomizeReports & Access Analysts onevery Report Purchase.
Purchasing this report?
For media enquiries,
please drop us a mail [email protected]
We’ll include an hour with our analysts to discuss the report findings.
For free.
USA – CANADA – UK – CHINA – INDIA
Access the Report
USA – CANADA – UK – CHINA – INDIA
India: An Overview
USA – CANADA – UK – CHINA – INDIA
About Us
USA – CANADA – UK – CHINA – INDIA
Thank You!
North America
Chicago, USA
Phone: +1 630 333 9501
Fax: +1 630 833 2171
Europe
London, United Kingdom
Phone: +44 208 123 1770
Fax: +44 845 280 2825
Asia
Bangalore, India
Phone: +91 934 254 0560
Fax: +91 80 4080 6070
DISCLAIMER
This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be
used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall
Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research
has been advised of the possibility of such damages.
Copyright ©2013 Infiniti Research Limited. All Rights Reserved.
Reproduction without written permission is completely forbidden.
NOT FOR FURTHER DISTRIBUTION
